VEGFA and retinopathy of prematurity: Despite the risk of PAR after anti-VEGF therapy (23, 24), our group has previously demonstrated that repeated IVR can still be effective in treating the reactivation of ROP and can promotes further vascularization and reduces the area of PAR (17).